4.7 Article

lncRNA-H19 in Fibroblasts Promotes Wound Healing in Diabetes

期刊

DIABETES
卷 71, 期 7, 页码 1562-1578

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db21-0724

关键词

-

资金

  1. Xuhui District Medical Research Project of Shanghai [SHXH201802, SHXH201606]
  2. Shanghai Municipal Key Clinical Specialty [shslczdzk00901]

向作者/读者索取更多资源

In this study, it was found that PDGFR alpha(+) fibroblast-expressing lncRNA-H19 plays an important role in promoting wound healing. This lncRNA accelerates wound healing by promoting dermal fibroblast proliferation and macrophage infiltration, and it does so by inhibiting p53 activity and GDF15 releasement.
Cutaneous wound healing in diabetes is impaired and would develop into nonhealing ulcerations. However, the molecular mechanism underlying the wound-healing process remains largely obscure. Here, we found that cutaneous PDGFR alpha(+) fibroblast-expressing lncRNA-H19 (lncH19) accelerates the wound-healing process via promoting dermal fibroblast proliferation and macrophage infiltration in injured skin. PDGFR alpha(+) cell-derived lncH19, which is lower in contents in the wound-healing cutaneous tissue of patients and mice with type 2 diabetes, is required for wound healing through promoting proliferative capacity of dermis fibroblasts as well as macrophage recruitments. Mechanistically, lncH19 relieves the cell cycle arrest of fibroblasts and increases macrophage infiltration in injured tissues via inhibiting p53 activity and GDF15 releasement. Furthermore, exosomes derived from adipocyte progenitor cells efficiently restore the impaired diabetic wound healing via delivering lncH19 to injured tissue. Therefore, our study reveals a new role for lncRNA in regulating cutaneous tissue repair and provides a novel promising insight for developing clinical treatment of diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据